Global Biopharmaceuticals Market is Projected to Grow by 8.7% through to 2025 and Reach $446 Billion - Market Report (2018-2025) by Industry Experts, Inc.
Industry Experts, Inc. published an updated 2019 version of the global market report on Biopharmaceuticals. As per the new report entitled "Biopharmaceuticals – A Global Market Overview", Oncology constitutes the largest, as also the fastest, growing application for Biopharmaceuticals globally, which is expected to register a CAGR of 10.6% over 2018-2025.
The biopharmaceuticals market is driven by various factors, such as increase in elderly population, surge in prevalence of chronic diseases like cancer, HIV/AIDS and diabetes, and increase in adoption of biopharmaceuticals globally. Biopharmaceuticals offer several benefits including highly effective and potent action, fewer side effects, and the potential to actually cure diseases rather than merely treat the symptoms, which have significantly increased the demand for biopharmaceutical products. The market growth is attributed to the growing acceptance for biopharmaceuticals due to their ability to treat previously untreatable diseases, resulting in huge market demand for biopharmaceuticals.
Global demand for Biopharmaceuticals by product is led by Monoclonal Antibodies (moAb), estimated at US$82.3 billion (33.2% share) in 2018, and is also projected to witness the fastest CAGR of 10.8% between 2018 and 2025. The global market for biopharmaceuticals in 2019 is expected to reach US$269.3 billion.
The report reviews, analyzes and projects the biopharmaceuticals market for the period 2016-2025 in terms of USD. Biopharmaceuticals product segments analyzed in this study comprises Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Others. Applications or therapeutic areas analyzed in this study comprises Oncology, Autoimmune Disorders, Diabetes, Inflammatory & Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others.
The global market for biopharmaceuticals is segmented into five regions namely, North America, Europe, Asia-Pacific, South America and Rest of World. The regional markets further analyzed for 14 independent countries across North America – The United States, Canada and Mexico; Europe – Germany, France, United Kingdom, Italy and Spain; Asia-Pacific – Japan, China, India and South Korea; and South America – Argentina and Brazil.
This 480 page global market report on Biopharmaceuticals includes 256 charts (includes a data table and graphical representation for each table), supported with a meaningful and easy to understand graphical presentation, of the market. The statistical tables represent the data for the global market by geographic region, product type and major application. This report includes the brief business profiles of 21 key global players and 58 major players across the North America – 25; Europe – 13; Asia-Pacific – 18; and Rest of World – 2. The report also provides the listing of the companies engaged in research & development, manufacturing and supply of Biopharmaceuticals. The global list of companies covers addresses, contact numbers and the website addresses of 843 companies.
California, USA based Industry Experts, Inc. is a multi-industry focused market research provider.
For more details: http://industry-experts.com/verticals/biotechnology/biopharmaceuticals-a-global-market-overview
The biopharmaceuticals market is driven by various factors, such as increase in elderly population, surge in prevalence of chronic diseases like cancer, HIV/AIDS and diabetes, and increase in adoption of biopharmaceuticals globally. Biopharmaceuticals offer several benefits including highly effective and potent action, fewer side effects, and the potential to actually cure diseases rather than merely treat the symptoms, which have significantly increased the demand for biopharmaceutical products. The market growth is attributed to the growing acceptance for biopharmaceuticals due to their ability to treat previously untreatable diseases, resulting in huge market demand for biopharmaceuticals.
Global demand for Biopharmaceuticals by product is led by Monoclonal Antibodies (moAb), estimated at US$82.3 billion (33.2% share) in 2018, and is also projected to witness the fastest CAGR of 10.8% between 2018 and 2025. The global market for biopharmaceuticals in 2019 is expected to reach US$269.3 billion.
The global market for biopharmaceuticals is segmented into five regions namely, North America, Europe, Asia-Pacific, South America and Rest of World. The regional markets further analyzed for 14 independent countries across North America – The United States, Canada and Mexico; Europe – Germany, France, United Kingdom, Italy and Spain; Asia-Pacific – Japan, China, India and South Korea; and South America – Argentina and Brazil.
This 480 page global market report on Biopharmaceuticals includes 256 charts (includes a data table and graphical representation for each table), supported with a meaningful and easy to understand graphical presentation, of the market. The statistical tables represent the data for the global market by geographic region, product type and major application. This report includes the brief business profiles of 21 key global players and 58 major players across the North America – 25; Europe – 13; Asia-Pacific – 18; and Rest of World – 2. The report also provides the listing of the companies engaged in research & development, manufacturing and supply of Biopharmaceuticals. The global list of companies covers addresses, contact numbers and the website addresses of 843 companies.
California, USA based Industry Experts, Inc. is a multi-industry focused market research provider.
For more details: http://industry-experts.com/verticals/biotechnology/biopharmaceuticals-a-global-market-overview
Comments
Post a Comment